Purpose

The Mini-Symposium Series on New Approach Methodologies (NAMs) for Preclinical HIV Research is a trans-NIH collaboration focused on advancing human-relevant NAM platforms for HIV research. The series will convene experts across biomedical research, clinical development, regulatory science, and related fields to highlight emerging evidence, identify key gaps, and discuss practical approaches for integrating NAMs with existing preclinical methods. Sessions will explore applications across HIV pathogenesis, therapeutics, prevention, latency, and cure research, while addressing platform readiness, validation pathways, safety assessment, and regulatory considerations. Participants are invited to register to receive meeting details and join collaborative discussions aimed at accelerating the evaluation, acceptance, and adoption of NAMs in preclinical HIV research.

Mini-Symposium Schedule

Mini-Symposium #1: Igniting the Pipeline: Preclinical Advances in NAMs for HIV
Date/Time: August 31, 1:00 p.m. – 5:00 p.m. EDT
Chairs: Lis Caler, Tania Lombo, Vasundhara Varthakavi, and Dwight Yin

Mini-Symposium #2: Modeling Immunity to HIV: Bridging Preclinical Discovery to Clinical Evaluation
Date/Time: September 10, 11:45 a.m. – 4:30 p.m. EDT
Chairs: Anjali Singh, Vasudev Rao, and Uday Shankar

Mini-Symposium #3: Preclinical Models and NAMs in HIV Research: Priority Use Models, Platform Readiness, and Validation Pathways
Date/Time: September 18, 12:00 noon – 4:00 p.m. EDT
Chairs: David Chang, Sai Maji, and Yongjun Sui